WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924033795 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849335914268983296 |
|---|---|
| author | Jonathan Barratt Biruh Workeneh Sung Gyun Kim Eun Young Lee Chun Lam Bess Sorensen Yuanbo Song Zeeshan Khawaja Laura Kooienga |
| author_facet | Jonathan Barratt Biruh Workeneh Sung Gyun Kim Eun Young Lee Chun Lam Bess Sorensen Yuanbo Song Zeeshan Khawaja Laura Kooienga |
| author_sort | Jonathan Barratt |
| collection | DOAJ |
| format | Article |
| id | doaj-art-70ecd7b4401f45e8a4eaf84b081da80a |
| institution | Kabale University |
| issn | 2468-0249 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-70ecd7b4401f45e8a4eaf84b081da80a2025-08-20T03:45:08ZengElsevierKidney International Reports2468-02492025-02-01102S769S77010.1016/j.ekir.2024.11.1357WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)Jonathan Barratt0Biruh Workeneh1Sung Gyun Kim2Eun Young Lee3Chun Lam4Bess Sorensen5Yuanbo Song6Zeeshan Khawaja7Laura Kooienga8Department of Cardiovascular Sciences, University of Leicester, Leicester, United KingdomMD Anderson Cancer Center, The University of Texas, Houston, TX, United StatesDept. of Internal Medicine, Div. of Nephrology, Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-do, Korea (Republic of)Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea (Republic of)Global Drug Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ, United StatesA Novartis Company, Chinook Therapeutics Inc, Seattle, WA, United StatesCell & Gene Therapy Full Dev Biostats, Novartis Pharmaceuticals Corporation, East Hanover, NJ, United StatesA Novartis Company, Chinook Therapeutics Inc, Seattle, WA, United StatesNephrology, Internal Medicine, Colorado Kidney Care, Denver, CO, United Stateshttp://www.sciencedirect.com/science/article/pii/S2468024924033795 |
| spellingShingle | Jonathan Barratt Biruh Workeneh Sung Gyun Kim Eun Young Lee Chun Lam Bess Sorensen Yuanbo Song Zeeshan Khawaja Laura Kooienga WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) Kidney International Reports |
| title | WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) |
| title_full | WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) |
| title_fullStr | WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) |
| title_full_unstemmed | WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) |
| title_short | WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) |
| title_sort | wcn25 1585 a phase 1 2 trial of zigakibart in iga nephropathy igan |
| url | http://www.sciencedirect.com/science/article/pii/S2468024924033795 |
| work_keys_str_mv | AT jonathanbarratt wcn251585aphase12trialofzigakibartiniganephropathyigan AT biruhworkeneh wcn251585aphase12trialofzigakibartiniganephropathyigan AT sunggyunkim wcn251585aphase12trialofzigakibartiniganephropathyigan AT eunyounglee wcn251585aphase12trialofzigakibartiniganephropathyigan AT chunlam wcn251585aphase12trialofzigakibartiniganephropathyigan AT besssorensen wcn251585aphase12trialofzigakibartiniganephropathyigan AT yuanbosong wcn251585aphase12trialofzigakibartiniganephropathyigan AT zeeshankhawaja wcn251585aphase12trialofzigakibartiniganephropathyigan AT laurakooienga wcn251585aphase12trialofzigakibartiniganephropathyigan |